365 related articles for article (PubMed ID: 32928270)
1. Infrared dermal thermometry is highly reliable in the assessment of patients with Charcot neuroarthropathy.
Dallimore SM; Puli N; Kim D; Kaminski MR
J Foot Ankle Res; 2020 Sep; 13(1):56. PubMed ID: 32928270
[TBL] [Abstract][Full Text] [Related]
2. Duration of total contact casting for resolution of acute Charcot foot: a retrospective cohort study.
Griffiths DA; Kaminski MR
J Foot Ankle Res; 2021 Jun; 14(1):44. PubMed ID: 34130722
[TBL] [Abstract][Full Text] [Related]
3. Asymmetrical attenuation of vibration sensation in unilateral diabetic Charcot foot neuroarthropathy.
Valabhji J; Marshall RC; Lyons S; Bloomfield L; Hogg D; Rosenfeld P; Gabriel CM
Diabet Med; 2012 Sep; 29(9):1191-4. PubMed ID: 22276944
[TBL] [Abstract][Full Text] [Related]
4. Charcot neuroarthropathy: An often overlooked complication of diabetes.
Botek G; Anderson MA; Taylor R
Cleve Clin J Med; 2010 Sep; 77(9):593-9. PubMed ID: 20810870
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus.
Rizzo P; Pitocco D; Zaccardi F; Di Stasio E; Strollo R; Rizzi A; Scavone G; Costantini F; Galli M; Tinelli G; Flex A; Caputo S; Pozzilli P; Landolfi R; Ghirlanda G; Nissim A
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27454862
[TBL] [Abstract][Full Text] [Related]
6. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy.
Gough A; Abraha H; Li F; Purewal TS; Foster AV; Watkins PJ; Moniz C; Edmonds ME
Diabet Med; 1997 Jul; 14(7):527-31. PubMed ID: 9223389
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
Jude EB; Selby PL; Burgess J; Lilleystone P; Mawer EB; Page SR; Donohoe M; Foster AV; Edmonds ME; Boulton AJ
Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835
[TBL] [Abstract][Full Text] [Related]
8. Charcot arthropathy of the foot and ankle associated with rheumatoid arthritis.
Grear BJ; Rabinovich A; Brodsky JW
Foot Ankle Int; 2013 Nov; 34(11):1541-7. PubMed ID: 23900228
[TBL] [Abstract][Full Text] [Related]
9. Conservative and Pharmacologic Treatments for the Diabetic Charcot Foot.
Petrova NL; Edmonds ME
Clin Podiatr Med Surg; 2017 Jan; 34(1):15-24. PubMed ID: 27865311
[TBL] [Abstract][Full Text] [Related]
10. Diabetic Charcot neuroarthropathy: The diagnosis must be considered in all diabetic neuropathic patients presenting with a hot, swollen foot.
Al-Busaidi IS; Mason R; Lunt H
N Z Med J; 2015 Oct; 128(1423):77-80. PubMed ID: 26645758
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous microvascular reactivity in Charcot neuroarthropathy: a systematic review and meta-analysis.
Lanting SM; Chan TL; Casey SL; Peterson BJ; Chuter VH
J Foot Ankle Res; 2022 Mar; 15(1):17. PubMed ID: 35232466
[TBL] [Abstract][Full Text] [Related]
12. Describing Normative Foot Temperatures in Patients With Diabetes-Related Peripheral Neuropathy.
Schmidt BM; Allison S; Wrobel JS
J Diabetes Sci Technol; 2020 Jan; 14(1):22-27. PubMed ID: 31315460
[TBL] [Abstract][Full Text] [Related]
13. [Early development of Charcot neuroarthropathy in the course of compensated diabetes mellitus--case report].
Kamińska A; Kamiński M; Jesionka P; Szymkowiak E; Bronisz A; Zmudzińska M; Junik R; Sikorska Z
Pol Arch Med Wewn; 2004 Jun; 111(6):709-13. PubMed ID: 15508794
[TBL] [Abstract][Full Text] [Related]
14. The role of genetic factors and monocyte-to-osteoclast differentiation in the pathogenesis of Charcot neuroarthropathy.
Kloska A; Korzon-Burakowska A; Malinowska M; Bruhn-Olszewska B; Gabig-Cimińska M; Jakóbkiewicz-Banecka J
Diabetes Res Clin Pract; 2020 Aug; 166():108337. PubMed ID: 32707214
[TBL] [Abstract][Full Text] [Related]
15. Management of the diabetic Charcot foot.
Frykberg RG; Mendeszoon E
Diabetes Metab Res Rev; 2000; 16 Suppl 1():S59-65. PubMed ID: 11054891
[TBL] [Abstract][Full Text] [Related]
16. The Diabetic Charcot Foot from 1936 to 2016: Eighty Years Later and Still Growing.
Ramanujam CL; Zgonis T
Clin Podiatr Med Surg; 2017 Jan; 34(1):1-8. PubMed ID: 27865310
[TBL] [Abstract][Full Text] [Related]
17. The consequences of complacency: managing the effects of unrecognized Charcot feet.
Wukich DK; Sung W; Wipf SA; Armstrong DG
Diabet Med; 2011 Feb; 28(2):195-8. PubMed ID: 21219429
[TBL] [Abstract][Full Text] [Related]
18. HIV neuropathy induced Charcot neuroarthropathy: a case discussion.
Young N; Neiderer K; Martin B; Jolley D; Dancho JF
Foot (Edinb); 2012 Sep; 22(3):112-6. PubMed ID: 22391513
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of charcot neuroarthropathy development in patients with type 2 diabetes.
Nehring P; Mrozikiewicz-Rakowska B; Maroszek P; Sobczyk-Kopcioł A; Krzyżewska M; Płoski R; Karnafel W
Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):31-4. PubMed ID: 24203651
[TBL] [Abstract][Full Text] [Related]
20. Role of body mass index in acute charcot neuroarthropathy.
Ross AJ; Mendicino RW; Catanzariti AR
J Foot Ankle Surg; 2013; 52(1):6-8. PubMed ID: 23260985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
